RISE Dispensaries makes its debut in Florida’s capital city with the opening of RISE Tallahassee on Mahan located at 2459 Mahan Drive, and RISE Tallahassee on Tennessee, located at 1412 W Tennessee Street Both locations are conveniently located off Highway 90 and bring the total footprint of RISE Dispensaries to 19 store locations across Florida RISE Tallahassee on Tennessee will host a grand opening ..read more

New dispensary expands patient access to medical marijuana with ribbon cutting and pop-up event TALLAHASSEE, Fla., July 11, 2024 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing marijuana company in the U.S., today announced the opening of a new Trulieve-affiliated medical marijuana dispensary in Wilkes-Barre, Pennsylvania. The ..read more

This marks the first export into Asia, the 18th international market for Aureus branded products and 21st market for all Avicanna products TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products is pleased to ..read more

Record Gross Revenue: Generated $9.4 million in gross revenue, establishing a new company record. Strong International Growth: International sales rose 26% to reach a record $3.7 million, now representing 45% of net revenue. Record Cash Flow from Operations1: $4.6 million, highlighting the Company's ability to produce sustainable and growing cash flows. Record Adjusted Net Income4: Achieved ..read more

LONG BEACH, Calif. and TORONTO, July 15, 2024 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., announced today the reappointment of Hector De La Torre to the Company's Board of Directors. Mr. De La Torre previously served as an original ..read more

SCOTTSDALE, AZ / ACCESSWIRE / July 15, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. is thrilled to announce that its high-strength CBD Pain Relief Cream is now available at the prestigious Red Hots Spa in Roslyn, NY & Garden City, NY. This partnership marks a significant milestone in the company's growth, enhancing brand's visibility and accessibility in ..read more

Vancouver, British Columbia--(Newsfile Corp. - July 16, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it has received dual-use Provisional Licenses from the Ohio Division of Cannabis Control (DCC), for its fully built-out cultivation and manufacturing facility as well as its ..read more

TEL AVIV, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that an additional patent application with the United States Patent and Trademark Office (“USPTO”) was submitted as part of its ongoing ..read more

SCOTTSDALE, AZ / ACCESSWIRE / July 16, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), through its dynamic subsidiary The CBD Vault Inc, is thrilled to announce a transformative partnership with Sunset Wholesale West, the premier wholesaler in Arizona. The collaboration will see The CBD Vault's exceptional pain creams, athlete-specific pain relief roll-ons, and acclaimed gummies distributed through Sunset ..read more

SciSparc will receive additional payments and execution fees if certain milestones are met TEL AVIV, Israel, July 17, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that it has signed a non-binding letter of ..read more